Introduction. Ehrlichia are obligate intracellular pathogens transmitted to vertebrates by ticks.
INTRODUCTION
Ehrlichiosis is a bacterial illness that affects humans and animals causing flu-like symptoms. Symptoms commonly associated with this illness include fever, headache, fatigue and muscle aches. The majority of Ehrlichia transmission occurs during the summer months, peaking May through July. Since the early 2000s, cases of ehrlichiosis have steadily increased, and the estimated case fatality rate is 1-2 % [1] . Many individuals have mild symptoms and never seek medical attention. However, life-threatening cases of ehrlichiosis manifest as septic shock, meningoencephalitis or acute respiratory distress syndrome (ARDS). Ehrlichia spreads throughout the body via the mononuclear phagocytic system and may infiltrate the brain meninges, lung, kidney, gastrointestinal tract and heart [2] . In severe cases, patients are at an increased risk of death if not treated appropriately and in a timely manner [1, 2] . Despite low penetration into the cerebrospinal fluid (CSF), doxycycline is the treatment of choice for all patients with ehrlichiosis, and should be initiated as part of empiric therapy for patients living in an area where Ehrlichia is endemic [3] . Tick-borne meningoencephalitis is most common in adults, with increasing age being associated with less favourable outcomes [3] .
CASE REPORT
The following is a case presentation of a 59-year-old white male with a past medical history significant for depression and alcohol abuse, who was admitted to the emergency department at the University of Kentucky Albert B. Chandler Medical Center, Lexington, KY, USA, in spring 2017 with encephalopathy after being found fallen down in the woods. The patient was intubated prior to arrival due to altered mentation. Home medications included dexlansoprazole, venlafaxine, hydroxyzine, sulfasalazine, triamcinolone cream and amitriptyline. According to the patient's pharmacy, he had no known medication allergies. The patient's family was unable to provide an extensive past medical history, but indicated the patient lived alone in a cabin in the woods.
INVESTIGATIONS
In the emergency department, the patient was febrile with a temperature of 103.5 F (39.7 C), a heart rate of 101 beats min À1 and blood pressure of 97/66 mmHg. An electrocardiogram was significant for a QRS interval of 104 ms, and a urine drug screen was positive for amitriptyline, venlafaxine and ketamine, which the patient received during intubation.
Serum alcohol, acetaminophen and salicylate levels were undetectable. Given the mildly prolonged QRS interval and the presence of amitriptyline in the patient's urine, he was given a 50 ml bolus of sodium bicarbonate 1 mEq ml
À1
and started on a sodium bicarbonate infusion 0.15 mEq ml À1 due to concern for possible tricyclic antidepressant overdose. Other significant laboratory results included a white blood cell (WBC) count of 3.6Â10 3 ) and alanine aminotransferase (ALT) of 42 U l À1 (normal range 11-41 U l À1 ). A computed tomography (CT) scan of the head, abdomen and pelvis was normal; however, a CT scan of the chest was positive for basilar consolidations. Given the patient's clinical presentation, meningitis was considered in the diagnostic differential. A lumbar puncture (LP) was performed, and the patient was started on acyclovir [600 mg intravenously (IV) every 8 h], ampicillin (2 g IV every 4 h), ceftriaxone (2 g IV every 12 h) and vancomycin [1250 mg (~13.4 mg kg À1 ) IV every 12 h] empirically. Blood, urine and sputum cultures, as well as meningitis/encephalitis panel PCR, were obtained from the patient prior to initiation of antibiotics. The organisms tested in the meningitis/encephalitis panel included: Escherichia coli K1, Haemophilus influenzae, Listeria monocytogenes, Neisseria meningitidis, Streptococcus agalactiae, Streptococcus pneumoniae, Cryptococcus neoformans/Cryptococcus gattii, cytomegalovirus, enterovirus, herpes simplex virus 1/2/6, human parechovirus and varicella zoster virus.
DIAGNOSIS
The following day, the results of the LP revealed a CSF WBC count of 28Â10 3 ). The LP results at this time were evident for bacterial meningitis. Due to the severity of the patient's illness, and abnormally low WBC and platelet count, along with the history of living in the woods, intravenous doxycycline (100 mg twice daily) was started on day 2 of hospitalization for possible tick-borne disease. Prior to the administration of doxycycline, a serum DNA PCR test was sent to a reference lab, LabCorp Burlington NC, USA to test for Anaplasma phagocytophilum and Ehrlichia chaffeensis antibodies, both potential tick-borne illnesses most commonly seen in the south-eastern and south-central region of the USA. On day 3 of hospitalization, the patient had improvement in mental status, which was approximately 24 h after the initiation of doxycycline. The patient was awake and alert, and able to follow commands. At this time, the patient was successfully liberated from mechanical ventilation. The meningitis/encephalitis panel by PCR, along with the CSF culture, was negative. By day 5 of the patient's hospital course, blood, urine and sputum cultures all revealed a final negative result. The infectious disease consult team recommended discontinuation of all antimicrobials except for doxycycline, as this patient fit an ehrlichial meningoencephalitis picture given the patient's abnormal laboratory test values and abnormal LP results.
OUTCOME AND FOLLOW UP
On hospital day 8, the DNA PCR resulted as negative for Anaplasma phagocytophilum antibodies and positive for Ehrlichia chaffeensis antibodies; the diagnosis of ehrlichial meningoencephalitis was confirmed. The results of this test took 6 days to return. By this time, the patient was afebrile with a temperature of 98.8 F (37.1 C) and continued to have rapid improvement in mental status. The patient's WBC level had come up to 4.3Â10 3 cells l À1 , his platelet count improved to 217Â10 3 platelets µl À1 , the international normalized ratio had also normalized to 1.0. AST and ALT had come down to 52 and 36 U l À1 , respectively. The patient was transferred to progressive care on day 10, and continued the doxycycline treatment for a 14 day course of therapy.
DISCUSSION
Human monocytic ehrlichiosis, caused by Ehrlichia chaffeensis, is commonly seen in the south-eastern and southcentral USA, transmitted via the lone star tick [4] . This disease typically manifests as a flu-like illness, in which patients experience fever, headache, chills, malaise, nausea, vomiting and diarrhoea. However, when not treated appropriately, the disease may be fatal. These Gram-negative intracellular bacteria form as a microcolony in cytoplasmic vacuoles of monocytes and spread throughout the body via the mononuclear phagocytic system. Ehrlichia secrete proteins that pass through the vacuole membrane and bind to the host's cytoplasmic proteins; thus, altering the host's response to the infection by decreasing the host's defence proteins such as IL-5, IL-18, chemokine receptors 2, 3 and 4, and MHC class II. While CD8 + T cells are thought to be immunoprotective, they also contribute to the lethal immunopathology of ehrlichiosis. CD8 + T cells overproduce TNFa, leading to the induction of apoptosis of hepatocytes [5] . High levels of serum TNF-a are associated with severe and fatal disease, which can present as a septic shock and multiple organ failure [6] .
Neurological manifestations of ehrlichiosis in humans are rarely reported in the literature. A PubMed (1959-2018) search was limited to the English language and humans using the keys words ehrlichiosis AND meningoencephalitis and revealed four case reports of CNS manifestations of ehrlichiosis, which are summarized in Table 1 [7] [8] [9] [10] .
The species of Ehrlichia in our patient's case was Ehrlichia chaffeensis, a species commonly found in the south-eastern and south-central USA [1] . This was confirmed by laboratory testing by LabCorp Burlington. If delayed identification leads to delayed treatment, this can worsen outcomes for these patients. A study by Hamburg et al. showed that patients who had a delay in the initiation of doxycycline for Platelets 51 k µl
À1
Diagnosed with Lyme and ehrlichia meningitis, promptly started on doxycycline, discharged home and did well at 4 week follow up.
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